Formulation of Budesonide-Loaded Polymeric Nanoparticles into Hydrogels for Local Therapy of Atopic Dermatitis

Budesonide is a mineral corticoid applied in the local therapy of pediatric atopic dermatitis. Unfortunately, its dermal administration is hindered by the concomitant adverse effects and its physicochemical properties. The characteristic pH change in the atopic lesions can be utilized for the prepar...

Full description

Bibliographic Details
Main Authors: Marta Slavkova, Christophor Lazov, Ivanka Spassova, Daniela Kovacheva, Ivanka Pencheva-El Tibi, Denitsa Stefanova, Virginia Tzankova, Petar D. Petrov, Krassimira Yoncheva
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Gels
Subjects:
Online Access:https://www.mdpi.com/2310-2861/10/1/79
_version_ 1797343869879189504
author Marta Slavkova
Christophor Lazov
Ivanka Spassova
Daniela Kovacheva
Ivanka Pencheva-El Tibi
Denitsa Stefanova
Virginia Tzankova
Petar D. Petrov
Krassimira Yoncheva
author_facet Marta Slavkova
Christophor Lazov
Ivanka Spassova
Daniela Kovacheva
Ivanka Pencheva-El Tibi
Denitsa Stefanova
Virginia Tzankova
Petar D. Petrov
Krassimira Yoncheva
author_sort Marta Slavkova
collection DOAJ
description Budesonide is a mineral corticoid applied in the local therapy of pediatric atopic dermatitis. Unfortunately, its dermal administration is hindered by the concomitant adverse effects and its physicochemical properties. The characteristic pH change in the atopic lesions can be utilized for the preparation of a pH-sensitive nanocarrier. In this view, the formulation of Eudragit L 100 nanoparticles as a budesonide delivery platform could provide more efficient release to the desired site, improve its penetration, and subsequently lower the undesired effects. In this study, budesonide-loaded Eudragit L100 nanoparticles were prepared via the nanoprecipitation method (mean diameter 57 nm, −31.2 mV, and approx. 90% encapsulation efficiency). Their safety was proven by cytotoxicity assays on the HaCaT keratinocyte cell line. Further, the drug-loaded nanoparticles were incorporated into two types of hydrogels based on methylcellulose or Pluronic F127. The formulated hydrogels were characterized with respect to their pH, occlusion, rheology, penetration, spreadability, and drug release. In conclusion, the developed hydrogels containing budesonide-loaded nanoparticles showed promising potential for the pediatric treatment of atopic dermatitis.
first_indexed 2024-03-08T10:54:05Z
format Article
id doaj.art-385186e0651d4a3d81290ed3ca5e8acb
institution Directory Open Access Journal
issn 2310-2861
language English
last_indexed 2024-03-08T10:54:05Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Gels
spelling doaj.art-385186e0651d4a3d81290ed3ca5e8acb2024-01-26T16:40:57ZengMDPI AGGels2310-28612024-01-011017910.3390/gels10010079Formulation of Budesonide-Loaded Polymeric Nanoparticles into Hydrogels for Local Therapy of Atopic DermatitisMarta Slavkova0Christophor Lazov1Ivanka Spassova2Daniela Kovacheva3Ivanka Pencheva-El Tibi4Denitsa Stefanova5Virginia Tzankova6Petar D. Petrov7Krassimira Yoncheva8Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaFaculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaInstitute of General and Inorganic Chemistry, Bulgarian Academy of Sciences, 1113 Sofia, BulgariaInstitute of General and Inorganic Chemistry, Bulgarian Academy of Sciences, 1113 Sofia, BulgariaFaculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaFaculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaFaculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaInstitute of Polymers, Bulgarian Academy of Sciences, Akad. G. Bonchev Str. 103A, 1113 Sofia, BulgariaFaculty of Pharmacy, Medical University of Sofia, 1000 Sofia, BulgariaBudesonide is a mineral corticoid applied in the local therapy of pediatric atopic dermatitis. Unfortunately, its dermal administration is hindered by the concomitant adverse effects and its physicochemical properties. The characteristic pH change in the atopic lesions can be utilized for the preparation of a pH-sensitive nanocarrier. In this view, the formulation of Eudragit L 100 nanoparticles as a budesonide delivery platform could provide more efficient release to the desired site, improve its penetration, and subsequently lower the undesired effects. In this study, budesonide-loaded Eudragit L100 nanoparticles were prepared via the nanoprecipitation method (mean diameter 57 nm, −31.2 mV, and approx. 90% encapsulation efficiency). Their safety was proven by cytotoxicity assays on the HaCaT keratinocyte cell line. Further, the drug-loaded nanoparticles were incorporated into two types of hydrogels based on methylcellulose or Pluronic F127. The formulated hydrogels were characterized with respect to their pH, occlusion, rheology, penetration, spreadability, and drug release. In conclusion, the developed hydrogels containing budesonide-loaded nanoparticles showed promising potential for the pediatric treatment of atopic dermatitis.https://www.mdpi.com/2310-2861/10/1/79budesonidenanoparticlesEudragit L100hydrogelsatopic dermatitis
spellingShingle Marta Slavkova
Christophor Lazov
Ivanka Spassova
Daniela Kovacheva
Ivanka Pencheva-El Tibi
Denitsa Stefanova
Virginia Tzankova
Petar D. Petrov
Krassimira Yoncheva
Formulation of Budesonide-Loaded Polymeric Nanoparticles into Hydrogels for Local Therapy of Atopic Dermatitis
Gels
budesonide
nanoparticles
Eudragit L100
hydrogels
atopic dermatitis
title Formulation of Budesonide-Loaded Polymeric Nanoparticles into Hydrogels for Local Therapy of Atopic Dermatitis
title_full Formulation of Budesonide-Loaded Polymeric Nanoparticles into Hydrogels for Local Therapy of Atopic Dermatitis
title_fullStr Formulation of Budesonide-Loaded Polymeric Nanoparticles into Hydrogels for Local Therapy of Atopic Dermatitis
title_full_unstemmed Formulation of Budesonide-Loaded Polymeric Nanoparticles into Hydrogels for Local Therapy of Atopic Dermatitis
title_short Formulation of Budesonide-Loaded Polymeric Nanoparticles into Hydrogels for Local Therapy of Atopic Dermatitis
title_sort formulation of budesonide loaded polymeric nanoparticles into hydrogels for local therapy of atopic dermatitis
topic budesonide
nanoparticles
Eudragit L100
hydrogels
atopic dermatitis
url https://www.mdpi.com/2310-2861/10/1/79
work_keys_str_mv AT martaslavkova formulationofbudesonideloadedpolymericnanoparticlesintohydrogelsforlocaltherapyofatopicdermatitis
AT christophorlazov formulationofbudesonideloadedpolymericnanoparticlesintohydrogelsforlocaltherapyofatopicdermatitis
AT ivankaspassova formulationofbudesonideloadedpolymericnanoparticlesintohydrogelsforlocaltherapyofatopicdermatitis
AT danielakovacheva formulationofbudesonideloadedpolymericnanoparticlesintohydrogelsforlocaltherapyofatopicdermatitis
AT ivankapenchevaeltibi formulationofbudesonideloadedpolymericnanoparticlesintohydrogelsforlocaltherapyofatopicdermatitis
AT denitsastefanova formulationofbudesonideloadedpolymericnanoparticlesintohydrogelsforlocaltherapyofatopicdermatitis
AT virginiatzankova formulationofbudesonideloadedpolymericnanoparticlesintohydrogelsforlocaltherapyofatopicdermatitis
AT petardpetrov formulationofbudesonideloadedpolymericnanoparticlesintohydrogelsforlocaltherapyofatopicdermatitis
AT krassimirayoncheva formulationofbudesonideloadedpolymericnanoparticlesintohydrogelsforlocaltherapyofatopicdermatitis